Avadel Pharmaceuticals PLC AVDL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/21/24 EDT
16.00quote price arrow up+0.30 (+1.91%)
Volume
518,000
52 week range
9.50 - 19.09
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close16.00
  • 52 Week High19.09
  • 52 Week High Date05/03/24
  • 52 Week Low9.50
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap1.538B
  • Shares Out96.12M
  • 10 Day Average Volume1.53M
  • Dividend-
  • Dividend Yield-
  • Beta1.73
  • YTD % Change13.31

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close16.00
  • 52 Week High19.09
  • 52 Week High Date05/03/24
  • 52 Week Low9.50
  • 52 Week Low Date10/27/23
  • Market Cap1.538B
  • Shares Out96.12M
  • 10 Day Average Volume1.53M
  • Dividend-
  • Dividend Yield-
  • Beta1.73
  • YTD % Change13.31

RATIOS/PROFITABILITY

  • EPS (TTM)-1.86
  • P/E (TTM)-8.60
  • Fwd P/E (NTM)-36.95
  • EBITDA (TTM)-133.867M
  • ROE (TTM)-780.02%
  • Revenue (TTM)55.141M
  • Gross Margin (TTM)95.71%
  • Net Margin (TTM)-284.42%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Avadel Pharmaceuticals PLC

 

Profile

MORE
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's lead product, LUMRYZ, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME and...
Geoffrey Glass
Non-Executive Independent Chairman of the Board
Gregory Divis Jr.
Chief Executive Officer, Director
Thomas McHugh
Chief Financial Officer
Address
Block 10-1 Blanchardstown Corporate Park
Ballycoolin
Dublin
15
Ireland

Top Peers

SYMBOLLASTCHG%CHG
OCUL
Ocular Therapeutix Inc
6.10-0.19-3.02%
EYPT
EyePoint Pharmaceuticals Inc
11.59-0.55-4.53%
SIGA
SIGA Technologies Inc
7.56+0.01+0.13%
HROW
Harrow Inc
16.49-0.30-1.79%
INVA
Innoviva Inc
16.15+0.02+0.12%